ESPEN guideline clinical nutrition in neurology

Published:September 21, 2017DOI:https://doi.org/10.1016/j.clnu.2017.09.003

      Summary

      Neurological diseases are frequently associated with swallowing disorders and malnutrition. Moreover, patients with neurological diseases are at increased risk of micronutrient deficiency and dehydration. On the other hand, nutritional factors may be involved in the pathogenesis of neurological diseases.
      Multiple causes for the development of malnutrition in patients with neurological diseases are known including oropharyngeal dysphagia, impaired consciousness, perception deficits, cognitive dysfunction, and increased needs.
      The present evidence- and consensus-based guideline addresses clinical questions on best medical nutrition therapy in patients with neurological diseases. Among them, management of oropharyngeal dysphagia plays a pivotal role. The guideline has been written by a multidisciplinary team and offers 88 recommendations for use in clinical practice for amyotrophic lateral sclerosis, Parkinson's disease, stroke and multiple sclerosis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dziewas R.
        • Beck A.M.
        • Clave P.
        • Hamdy S.
        • Heppner H.J.
        • Langmore S.E.
        • et al.
        Recognizing the importance of dysphagia: stumbling blocks and stepping stones in the twenty-first century.
        Dysphagia. 2017 Feb; 32 (https://doi.org/10.1007/s00455-016-9746-2. Epub 2016 Aug 29): 78-82
        • Dziewas R.
        • Glahn J.
        • Helfer C.
        • Ickenstein G.
        • Keller J.
        • Ledl C.
        • et al.
        Flexible endoscopic evaluation of swallowing (FEES) for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German stroke society.
        BMC Med Educ. 2016; 16: 70
        • Hoffmann S.
        • Malzahn U.
        • Harms H.
        • Koennecke H.-C.
        • Berger K.
        • Kalic M.
        • et al.
        Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke.
        Stroke. 2012 Oct 1; 43: 2617-2623
        • Martino R.
        • Foley N.
        • Bhogal S.
        • Diamant N.
        • Speechley M.
        • Teasell R.
        Dysphagia after stroke: incidence, diagnosis, and pulmonary complications.
        Stroke. 2005 Dec 1; 36: 2756-2763
        • Suntrup S.
        • Warnecke T.
        • Kemmling A.
        • Teismann I.K.
        • Hamacher C.
        • Oelenberg S.
        • et al.
        Dysphagia in patients with acute striatocapsular hemorrhage.
        J Neurol. 2012 Jan 7; 259: 93-99
        • Morgan A.S.
        • Mackay L.E.
        Causes and complications associated with swallowing disorders in traumatic brain injury.
        J Head Trauma Rehabil. 1999 Oct; 14: 454-461
        • Mackay L.E.
        • Morgan A.S.
        • Bernstein B.A.
        Factors affecting oral feeding with severe traumatic brain injury.
        J Head Trauma Rehabil. 1999 Oct; 14: 435-447
        • Müller J.
        • Wenning G.K.
        • Verny M.
        • McKee A.
        • Chaudhuri K.R.
        • Jellinger K.
        • et al.
        Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders.
        Arch Neurol. 2001 Feb; 58: 259-264
        • Miller N.
        • Noble E.
        • Jones D.
        • Burn D.
        Hard to swallow: dysphagia in Parkinson's disease.
        Age Ageing. 2006 Sep 2; 35: 614-618
        • Guan X.-L.
        • Wang H.
        • Huang H.-S.
        • Meng L.
        Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
        Neurol Sci. 2015 May 3; 36: 671-681
        • Calcagno P.
        • Ruoppolo G.
        • Grasso M.G.
        • De Vincentiis M.
        • Paolucci S.
        Dysphagia in multiple sclerosis - prevalence and prognostic factors.
        Acta Neurol Scand. 2002 Jan; 105: 40-43
        • Kühnlein P.
        • Gdynia H.-J.
        • Sperfeld A.-D.
        • Lindner-Pfleghar B.
        • Ludolph A.C.
        • Prosiegel M.
        • et al.
        Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis.
        Nat Clin Pract Neurol. 2008 Jul 17; 4: 366-374
        • Grob D.
        • Arsura E.L.
        • Brunner N.G.
        • Namba T.
        The course of myasthenia gravis and therapies affecting outcome.
        Ann N Y Acad Sci. 1987; 505: 472-499
        • Mulcahy K.P.
        • Langdon P.C.
        • Mastaglia F.
        Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence.
        Dysphagia. 2012 Mar 27; 27: 64-69
        • Tolep K.
        • Getch C.L.
        • Criner G.J.
        Swallowing dysfunction in patients receiving prolonged mechanical ventilation.
        Chest. 1996 Jan; 109: 167-172
        • Macht M.
        • Wimbish T.
        • Clark B.J.
        • Benson A.B.
        • Burnham E.L.
        • Williams A.
        • et al.
        Postextubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness.
        Crit Care. 2011; 15: R231
        • Wirth R.
        • Dziewas R.
        • Beck A.M.
        • Clavé P.
        • Hamdy S.
        • Heppner H.J.
        • et al.
        Oropharyngeal dysphagia in older persons – from pathophysiology to adequate intervention: a review and summary of an international expert meeting.
        Clin Interv Aging. 2016 Feb; 11: 189-208
        • Bischoff S.C.
        • Singer P.
        • Koller M.
        • Barazzoni R.
        • Cederholm T.
        • van Gossum A.
        Standard operating procedures for ESPEN guidelines and consensus papers.
        Clin Nutr. 2015; 34: 1043-1051
        • Wirth R.
        • Smoliner C.
        • Jäger M.
        • Warnecke T.
        • Leischker A.H.
        • Dziewas R.
        • et al.
        Guideline clinical nutrition in patients with stroke.
        Exp Transl Stroke Med. 2013 Dec 1; 5: 14
        • Gomes F.
        • Hookway C.
        • Weekes C.E.
        Royal college of physicians intercollegiate stroke working party. Royal college of physicians intercollegiate stroke working party evidence-based guidelines for the nutritional support of patients who have had a stroke.
        J Hum Nutr Diet. 2014 Apr; 27: 107-121
        • Geeganage C.
        • Beavan J.
        • Ellender S.
        • Bath P.M.W.
        Interventions for dysphagia and nutritional support in acute and subacute stroke.
        in: Cochrane database syst rev. vol. 10. 2012 Oct 17: CD000323
        • Scottish Intercollegiate Guidelines Network 50
        A guideline developer's handbook. Revised version.
        Edimburg, 2015 (SIGN 2014)
        • Cederholm T.
        • Barazzoni R.
        • Austin P.
        • Ballmer P.
        • Biolo G.
        • Bischoff S.C.
        • et al.
        ESPEN guidelines on definitions and terminology of clinical nutrition.
        Clin Nutr. 2017; 36: 49-64
        • Couratier P.
        • Corcia P.
        • Lautrette G.
        • Nicol M.
        • Preux P.-M.
        • Marin B.
        Epidemiology of amyotrophic lateral sclerosis: a review of literature.
        Rev Neurol (Paris). 2016 Jan; 172: 37-45
        • Naghavi M.
        • Wang H.
        • Lozano R.
        • Davis A.
        • Liang X.
        • Zhou M.
        • et al.
        Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
        Lancet. 2015; 385: 117-171
        • Chio A.
        • Logroscino G.
        • Hardiman O.
        • Swingler R.
        • Mitchell D.
        • Beghi E.
        • et al.
        Prognostic factors in ALS: a critical review.
        Amyotroph Lateral Scler. 2009 Jan 18; 10: 310-323
        • Desport J.-C.
        • Marin B.
        • Funalot B.
        • Preux P.-M.
        • Couratier P.
        Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
        Amyotroph Lateral Scler. 2008 Oct 10; 9: 273-278
        • Marin B.
        • Desport J.C.
        • Kajeu P.
        • Jesus P.
        • Nicolaud B.
        • Nicol M.
        • et al.
        Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients.
        J Neurol Neurosurg Psychiatry. 2011 Jun 1; 82: 628-634
        • Marin B.
        • Arcuti S.
        • Jesus P.
        • Logroscino G.
        • Copetti M.
        • Fontana A.
        • et al.
        Population-based evidence that survival in amyotrophic lateral sclerosis is related to weight loss at diagnosis.
        Neurodegener Dis. 2016 Feb 12; 16: 225-234
        • Bouteloup C.
        • Desport J.-C.
        • Clavelou P.
        • Guy N.
        • Derumeaux-Burel H.
        • Ferrier A.
        • et al.
        Hypermetabolism in ALS patients: an early and persistent phenomenon.
        J Neurol. 2009 Aug 22; 256: 1236-1242
        • Chiò A.
        • Calvo A.
        • Bovio G.
        • Canosa A.
        • Bertuzzo D.
        • Galmozzi F.
        • et al.
        Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
        JAMA Neurol. 2014 Sep; 71: 1134-1142
        • Dupuis L.
        • Corcia P.
        • Fergani A.
        • Gonzalez De Aguilar J.-L.
        • Bonnefont-Rousselot D.
        • Bittar R.
        • et al.
        Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
        Neurology. 2008 Mar 25; 70: 1004-1009
        • Rafiq M.K.
        • Lee E.
        • Bradburn M.
        • McDermott C.J.
        • Shaw P.J.
        Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: insights from the olesoxime clinical trial.
        Amyotroph Lateral Scler Front Degener. 2015 Nov 27; 16: 478-484
        • Dorst J.
        • Kühnlein P.
        • Hendrich C.
        • Kassubek J.
        • Sperfeld A.D.
        • Ludolph A.C.
        Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis.
        J Neurol. 2011 Apr 3; 258: 613-617
        • Desport J.C.
        • Preux P.M.
        • Truong T.C.
        • Vallat J.M.
        • Sautereau D.
        • Couratier P.
        Nutritional status is a prognostic factor for survival in ALS patients.
        Neurology. 1999 Sep 22; 53: 1059-1063
        • Paganoni S.
        • Deng J.
        • Jaffa M.
        • Cudkowicz M.E.
        • Wills A.-M.
        Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis.
        Muscle Nerve. 2011 Jul; 44: 20-24
        • Rio A.
        • Ellis C.
        • Shaw C.
        • Willey E.
        • Ampong M.-A.
        • Wijesekera L.
        • et al.
        Nutritional factors associated with survival following enteral tube feeding in patients with motor neurone disease.
        J Hum Nutr Diet. 2010 Aug; 23: 408-415
        • Shimizu T.
        • Nagaoka U.
        • Nakayama Y.
        • Kawata A.
        • Kugimoto C.
        • Kuroiwa Y.
        • et al.
        Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan.
        Amyotroph Lateral Scler. 2012; 13: 363-366
        • Roubeau V.
        • Blasco H.
        • Maillot F.
        • Corcia P.
        • Praline J.
        Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis.
        Muscle Nerve. 2015 Apr; 51: 479-484
        • Desport J.C.
        • Preux P.M.
        • Bouteloup-Demange C.
        • Clavelou P.
        • Beaufrère B.
        • Bonnet C.
        • et al.
        Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis.
        Am J Clin Nutr. 2003; 77: 1179-1185
        • Vaisman N.
        • Lusaus M.
        • Nefussy B.
        • Niv E.
        • Comaneshter D.
        • Hallack R.
        • et al.
        Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?.
        J Neurol Sci. 2009; 279: 26-29
        • Weijs P.J.M.
        Hypermetabolism, is it Real? The example of amyotrophic lateral sclerosis.
        J Am Diet Assoc. 2011 Nov; 111: 1670-1673
        • Sherman M.S.
        • Pillai A.
        • Jackson A.
        • Heiman-Patterson T.
        Standard equations are not accurate in assessing resting energy expenditure in patients with amyotrophic lateral sclerosis.
        J Parenter Enteral Nutr. 2004; 28: 442-446
        • Kasarskis E.J.
        • Mendiondo M.S.
        • Matthews D.E.
        • Mitsumoto H.
        • Tandan R.
        • Simmons Z.
        • et al.
        Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis 1–3.
        Am J Clin Nutr. 2014 Apr 1; 99: 792-803
        • Ellis A.C.
        • Rosenfeld J.
        Which equation best predicts energy expenditure in amyotrophic lateral sclerosis?.
        J Am Diet Assoc. 2011 Nov; 111: 1680-1687
        • Genton L.
        • Viatte V.
        • Janssens J.-P.
        • Héritier A.-C.
        • Pichard C.
        Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.
        Clin Nutr. 2011 Oct; 30: 553-559
        • Salvioni C.C.D.S.
        • Stanich P.
        • Almeida C.S.
        • Oliveira A.S.B.
        Nutritional care in motor neurone disease/amyotrophic lateral sclerosis.
        Arq Neuropsiquiatr. 2014; 72: 157-163
        • Georges M.
        • Morélot-Panzini C.
        • Similowski T.
        • Gonzalez-Bermejo J.
        Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis.
        BMC Pulm Med. 2014 Feb 7; 14: 17
        • Siirala W.
        • Olkkola K.T.
        • Noponen T.
        • Vuori A.
        • Aantaa R.
        Predictive equations over-estimate the resting energy expenditure in amyotrophic lateral sclerosis patients who are dependent on invasive ventilation support.
        Nutr Metab (Lond). 2010 Aug 26; 7: 70
        • Shimizu T.
        • Hayashi H.
        • Tanabe H.
        Energy metabolism of ALS patients under mechanical ventilation and tube feeding.
        Rinsho Shinkeigaku. 1991 Mar; 31: 255-259
        • Ichihara N.
        • Namba K.
        • Ishikawa-Takata K.
        • Sekine K.
        • Takase M.
        • Kamada Y.
        • et al.
        Energy requirement assessed by doubly-labeled water method in patients with advanced amyotrophic lateral sclerosis managed by tracheotomy positive pressure ventilation.
        Amyotroph Lateral Scler. 2012 Oct 13; 13: 544-549
        • Clavelou P.
        • Blanquet M.
        • Peyrol F.
        • Ouchchane L.
        • Gerbaud L.
        Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
        J Neurol Sci. 2013 Aug 15; 331: 126-131
        • Chiò A.
        • Finocchiaro E.
        • Meineri P.
        • Bottacchi E.
        • Schiffer D.
        Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group.
        Neurology. 1999 Sep 22; 53: 1123-1125
        • Héritier A.C.
        • Janssens J.P.
        • Adler D.
        • Ferfoglia R.I.
        • Genton L.
        Should patients with ALS gain weight during their follow-up?.
        Nutrition. 2015; 31: 1368-1371
        • Miller R.G.
        • Jackson C.E.
        • Kasarskis E.J.
        • England J.D.
        • Forshew D.
        • Johnston W.
        • et al.
        Practice Parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology.
        Neurology. 2009 Oct 13; 73: 1218-1226
        • Dorst J.
        • Cypionka J.
        • Ludolph A.C.
        High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study.
        Amyotroph Lateral Scler Front Degener. 2013 Dec 14; 14: 533-536
        • Andersen P.M.
        • Abrahams S.
        • Borasio G.D.
        • de Carvalho M.
        • Chio A.
        • Van Damme P.
        • et al.
        EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force.
        Eur J Neurol. 2012 Mar; 19: 360-375
        • Ruoppolo G.
        • Schettino I.
        • Frasca V.
        • Giacomelli E.
        • Prosperini L.
        • Cambieri C.
        • et al.
        Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings.
        Acta Neurol Scand. 2013 Dec; 128: 397-401
        • Hillel A.D.
        • Miller R.
        Bulbar amyotrophic lateral sclerosis: patterns of progression and clinical management.
        Head Neck. 1989; 11: 51-59
        • Mitsumoto H.
        • Chad D.A.
        • Pioro E.P.
        Amyotrophic lateral sclerosis.
        F.A. Davis, 1998: 480
        • Greenwood D.I.
        Nutrition management of amyotrophic lateral sclerosis.
        Nutr Clin Pract. 2013 Jun 1; 28: 392-399
        • D'Ottaviano F.G.
        • Linhares Filho T.A.
        • Andrade H.M.
        • Alves P.C.
        • Rocha M.S.
        Fiberoptic endoscopy evaluation of swallowing in patients with amyotrophic lateral sclerosis.
        Braz J Otorhinolaryngol. 2013 May; 79: 349-353
        • Paris G.
        • Martinaud O.
        • Petit A.
        • Cuvelier A.
        • Hannequin D.
        • Roppeneck P.
        • et al.
        Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life.
        J Oral Rehabil. 2013 Mar; 40: 199-204
        • Erdem N.S.
        • Karaali K.
        • Ünal A.
        • Kızılay F.
        • Öğüş C.
        • Uysal H.
        The interaction between breathing and swallowing in amyotrophic lateral sclerosis.
        Acta Neurol Belg. 2016 Dec 5; 116: 549-556
        • Riancho J.
        • Lozano-Cuesta P.
        • Santurtún A.
        • Sánchez-Juan P.
        • López-Vega J.M.
        • Berciano J.
        • et al.
        Amyotrophic lateral sclerosis in northern Spain 40 Years later: what has changed?.
        Neurodegener Dis. 2016; 16: 337-341
        • Rodríguez de Rivera F.J.
        • Oreja Guevara C.
        • Sanz Gallego I.
        • San José Valiente B.
        • Santiago Recuerda A.
        • Gómez Mendieta M.A.
        • et al.
        Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit.
        Neurologia. 2011 Oct; 26: 455-460
        • Körner S.
        • Hendricks M.
        • Kollewe K.
        • Zapf A.
        • Dengler R.
        • Silani V.
        • et al.
        Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.
        BMC Neurol. 2013 Jul 12; 13: 84
        • Jesus P.
        • Massoulard A.
        • Marin B.
        • Nicol M.
        • Laplagne O.
        • Baptiste A.
        • et al.
        First assessment at home of amyotrophic lateral sclerosis (ALS) patients by a nutrition network in the French region of Limousin.
        Amyotroph Lateral Scler. 2012 Oct 9; 13: 538-543
        • Yokoi D.
        • Atsuta N.
        • Watanabe H.
        • Nakamura R.
        • Hirakawa A.
        • Ito M.
        • et al.
        Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis.
        J Neurol. 2016 Jun 15; 263: 1129-1136
        • Limousin N.
        • Blasco H.
        • Corcia P.
        • Gordon P.H.
        • De Toffol B.
        • Andres C.
        • et al.
        Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.
        J Neurol Sci. 2010 Oct 15; 297: 36-39
        • Mazzini L.
        • Corrà T.
        • Zaccala M.
        • Mora G.
        • Del Piano M.
        • Galante M.
        Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis.
        J Neurol. 1995 Oct; 242: 695-698
        • Sorenson E.J.
        • Crum B.
        • Stevens J.C.
        Incidence of aspiration pneumonia in ALS in Olmsted county, MN.
        Amyotroph Lateral Scler. 2007 Apr 10; 8: 87-89
        • Kurian K.M.
        • Forbes R.B.
        • Colville S.
        • Swingler R.J.
        Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register.
        J Neurol Neurosurg Psychiatry. 2009 Jan 1; 80: 84-87
        • Hillel A.D.
        • Miller R.M.
        • Yorkston K.
        • McDonald E.
        • Norris F.H.
        • Konikow N.
        Amyotrophic lateral sclerosis severity scale.
        Neuroepidemiology. 1989; 8: 142-150
        • Wada A.
        • Kawakami M.
        • Liu M.
        • Otaka E.
        • Nishimura A.
        • Liu F.
        • et al.
        Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS).
        J Neurol. 2015 Oct 4; 262: 2225-2231
        • Heffernan C.
        • Jenkinson C.
        • Holmes T.
        • Feder G.
        • Kupfer R.
        • Leigh P.N.
        • et al.
        Nutritional management in MND/ALS patients: an evidence based review.
        Amyotroph Lateral Scler Other Mot Neuron Disord. 2004 Jun 10; 5: 72-83
        • Plowman E.K.
        • Tabor L.C.
        • Robison R.
        • Gaziano J.
        • Dion C.
        • Watts S.A.
        • et al.
        Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis.
        Neurogastroenterol Motil. 2016 Jan; 28: 85-90
        • Clavé P.
        • Arreola V.
        • Romea M.
        • Medina L.
        • Palomera E.
        • Serra-Prat M.
        Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration.
        Clin Nutr. 2008 Dec; 27: 806-815
        • Plowman E.K.
        • Watts S.A.
        • Robison R.
        • Tabor L.
        • Dion C.
        • Gaziano J.
        • et al.
        Voluntary cough airflow differentiates safe versus unsafe swallowing in amyotrophic lateral sclerosis.
        Dysphagia. 2016 Jun 23; 31: 383-390
        • Solazzo A.
        • Del Vecchio L.
        • Reginelli A.
        • Monaco L.
        • Sagnelli A.
        • Monsorrò M.
        • et al.
        Search for compensation postures with videofluoromanometric investigation in dysphagic patients affected by amyotrophic lateral sclerosis.
        Radiol Med. 2011 Oct 4; 116: 1083-1094
        • Wright R.
        • Jordan C.
        Videofluoroscopic evaluation of dysphagia in motor neurone disease with modified barium swallow.
        Palliat Med. 1997 Jan; 11: 44-48
        • Briani C.
        • Marcon M.
        • Ermani M.
        • Costantini M.
        • Bottin R.
        • Iurilli V.
        • et al.
        Radiological evidence of subclinical dysphagia in motor neuron disease.
        J Neurol. 1998 Apr; 245: 211-216
        • Higo R.
        • Tayama N.
        • Nito T.
        Longitudinal analysis of progression of dysphagia in amyotrophic lateral sclerosis.
        Auris Nasus Larynx. 2004 Sep; 31: 247-254
        • Lo Re G.
        • Galia M.
        • La Grutta L.
        • Russo S.
        • Runza G.
        • Taibbi A.
        • et al.
        Digital cineradiographic study of swallowing in patients with amyotrophic lateral sclerosis.
        Radiol Med. 2007 Dec 13; 112: 1173-1187
        • Murono S.
        • Hamaguchi T.
        • Yoshida H.
        • Nakanishi Y.
        • Tsuji A.
        • Endo K.
        • et al.
        Evaluation of dysphagia at the initial diagnosis of amyotrophic lateral sclerosis.
        Auris Nasus Larynx. 2015 Jun; 42: 213-217
        • Kawai S.
        • Tsukuda M.
        • Mochimatsu I.
        • Enomoto H.
        • Kagesato Y.
        • Hirose H.
        • et al.
        A study of the early stage of dysphagia in amyotrophic lateral sclerosis.
        Dysphagia. 2003 Feb 1; 18: 1-8
        • Solazzo A.
        • Monaco L.
        • Del Vecchio L.
        • Reginelli A.
        • Iacobellis F.
        • Capasso R.
        • et al.
        Earliest videofluoromanometric pharyngeal signs of dysphagia in ALS patients.
        Dysphagia. 2014 Oct 21; 29: 539-544
        • Goeleven A.
        • Robberecht W.
        • Sonies B.
        • Carbonez A.
        • Dejaeger E.
        Manofluorographic evaluation of swallowing in amyotrophic lateral sclerosis and its relationship with clinical evaluation of swallowing.
        Amyotroph Lateral Scler. 2006 Dec 10; 7: 235-240
        • Higo R.
        • Tayama N.
        • Watanabe T.
        • Nitou T.
        Videomanofluorometric study in amyotrophic lateral sclerosis.
        Laryngoscope. 2002 May; 112: 911-917
        • Dziewas R.
        • Glahn J.
        • Helfer C.
        • Ickenstein G.
        • Keller J.
        • Lapa S.
        • et al.
        FEES for neurogenic dysphagia: training curriculum of the German society of Neurology and the German stroke society.
        Nervenarzt. 2014; 85: 1006-1015
        • Leder S.
        • Novella S.
        • Patwa H.
        Use of fiberoptic endoscopic evaluation of swallowing (FEES) in patients with amyotrophic lateral sclerosis.
        Dysphagia. 2004 Aug; 19: 177-181
        • Nakamori M.
        • Hosomi N.
        • Takaki S.
        • Oda M.
        • Hiraoka A.
        • Yoshikawa M.
        • et al.
        Tongue thickness evaluation using ultrasonography can predict swallowing function in amyotrophic lateral sclerosis patients.
        Clin Neurophysiol. 2016 Feb; 127: 1669-1674
        • Tamburrini S.
        • Solazzo A.
        • Sagnelli A.
        • Del Vecchio L.
        • Reginelli A.
        • Monsorrò M.
        • et al.
        Amyotrophic lateral sclerosis: sonographic evaluation of dysphagia.
        Radiol Med. 2010 Aug 19; 115: 784-793
        • Rosenbek J.C.
        • Robbins J.A.
        • Roecker E.B.
        • Coyle J.L.
        • Wood J.L.
        A penetration-aspiration scale.
        Dysphagia. 1996; 11: 93-98
        • Muscaritoli M.
        • Kushta I.
        • Molfino A.
        • Inghilleri M.
        • Sabatelli M.
        • Rossi Fanelli F.
        Nutritional and metabolic support in patients with amyotrophic lateral sclerosis.
        Nutrition. 2012 Oct; 28: 959-966
        • Palovcak M.
        • Mancinelli J.M.
        • Elman L.B.
        • McCluskey L.
        Diagnostic and therapeutic methods in the management of dysphagia in the ALS population: issues in efficacy for the out-patient setting.
        NeuroRehabilitation. 2007; 22: 417-423
        • National Institute for Healt and Care Excellence
        Motor neurone disease: assessment and management.
        London Natl Inst Heal Care Excell (UK), 2016 ([February])
        • Wills A.-M.
        • Hubbard J.
        • Macklin E.A.
        • Glass J.
        • Tandan R.
        • Simpson E.P.
        • et al.
        Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.
        Lancet (London, England). 2014 Jun 14; 383: 2065-2072
      1. Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis - Full Text View - ClinicalTrials.gov [Internet]. [cited 2017 Jan 1]. Available from: https://clinicaltrials.gov/ct2/show/NCT02306590?term=ALS+and+high+caloric+diet&rank=1.

        • Mitsumoto H.
        • Davidson M.
        • Moore D.
        • Gad N.
        • Brandis M.
        • Ringel S.
        • et al.
        Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction.
        Amyotroph Lateral Scler Other Mot Neuron Disord. 2003 Sep; 4: 177-185
        • Katzberg H.D.
        • Benatar M.
        Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.
        in: Katzberg H.D. Cochrane database of systematic reviews. John Wiley & Sons, Ltd, Chichester, UK2011: CD004030
        • Morassutti I.
        • Giometto M.
        • Baruffi C.
        • Marcon M.L.
        • Michieletto S.
        • Giometto B.
        • et al.
        Nutritional intervention for amyotrophic lateral sclerosis.
        Minerva Gastroenterol Dietol. 2012 Sep; 58: 253-260
        • Zoccolella S.
        • Beghi E.
        • Palagano G.
        • Fraddosio A.
        • Guerra V.
        • Samarelli V.
        • et al.
        Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study.
        J Neurol Neurosurg Psychiatry. 2008 Jan 1; 79: 33-37
        • Chhetri S.K.
        • Bradley B.F.
        • Majeed T.
        • Lea R.W.
        Motor neurone disease in Lancashire and south cumbria in north west England and an 8 year experience with enteral nutrition.
        J Clin Neurosci. 2016 Feb; 24: 47-51
        • Atsuta N.
        • Watanabe H.
        • Ito M.
        • Tanaka F.
        • Tamakoshi A.
        • Nakano I.
        • et al.
        Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis.
        J Neurol Sci. 2009 Jan 15; 276: 163-169
        • Ludolph A.C.
        135th ENMC International Workshop: nutrition in amyotrophic lateral sclerosis 18-20 of March 2005, Naarden, The Netherlands.
        Neuromuscul Disord. 2006 Aug; 16: 530-538
        • ProGas Study Group
        Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study.
        Lancet Neurol. 2015 Jul; 14: 702-709
        • Dorst J.
        • Dupuis L.
        • Petri S.
        • Kollewe K.
        • Abdulla S.
        • Wolf J.
        • et al.
        Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.
        J Neurol. 2015 Apr 25; 262: 849-858
        • Chiò A.
        • Galletti R.
        • Finocchiaro C.
        • Righi D.
        • Ruffino M.A.
        • Calvo A.
        • et al.
        Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS.
        J Neurol Neurosurg Psychiatry. 2004 Apr; 75: 645-647
        • Sarfaty M.
        • Nefussy B.
        • Gross D.
        • Shapira Y.
        • Vaisman N.
        • Drory V.E.
        Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction.
        Amyotroph Lateral Scler Front Degener. 2013 Dec 25; 14: 528-532
        • Pena M.J.
        • Ravasco P.
        • Machado M.
        • Pinto A.
        • Pinto S.
        • Rocha L.
        • et al.
        What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?.
        Amyotroph Lateral Scler. 2012 Oct 18; 13: 550-554
        • Spataro R.
        • Ficano L.
        • Piccoli F.
        • La Bella V.
        Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival.
        J Neurol Sci. 2011 May 15; 304: 44-48
        • Desport J.-C.
        • Mabrouk T.
        • Bouillet P.
        • Perna A.
        • Preux P.-M.
        • Couratier P.
        Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis.
        Amyotroph Lateral Scler Other Mot Neuron Disord. 2005 Jun 10; 6: 88-93
        • Thornton F.J.
        • Fotheringham T.
        • Alexander M.
        • Hardiman O.
        • McGrath F.P.
        • Lee M.J.
        Amyotrophic lateral sclerosis: enteral nutrition provision—endoscopic or radiologic gastrostomy?.
        Radiology. 2002 Sep; 224: 713-717
        • Allen J.A.
        • Chen R.
        • Ajroud-Driss S.
        • Sufit R.L.
        • Heller S.
        • Siddique T.
        • et al.
        Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: a retrospective study of complications and outcome.
        Amyotroph Lateral Scler Front Degener. 2013 May 4; 14: 308-314
        • Stavroulakis T.
        • Walsh T.
        • Shaw P.J.
        • McDermott C.J.
        • Progas Study
        Gastrostomy use in motor neurone disease (MND): a review, meta-analysis and survey of current practice.
        Amyotroph Lateral Scler Front Degener. 2013 Mar 17; 14: 96-104
        • Verschueren A.
        • Monnier A.
        • Attarian S.
        • Lardillier D.
        • Pouget J.
        Enteral and parenteral nutrition in the later stages of ALS: an observational study.
        Amyotroph Lateral Scler. 2009 Feb 10; 10: 42-46
        • Abdelnour-Mallet M.
        • Verschueren A.
        • Guy N.
        • Soriani M.-H.
        • Chalbi M.
        • Gordon P.
        • et al.
        Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: a French national survey.
        Amyotroph Lateral Scler. 2011 May 15; 12: 178-184
        • Armon C.
        Sports and trauma in amyotrophic lateral sclerosis revisited.
        J Neurol Sci. 2007 Nov 15; 262: 45-53
        • Huisman M.H.B.
        • Seelen M.
        • de Jong S.W.
        • Dorresteijn K.R.I.S.
        • van Doormaal P.T.C.
        • van der Kooi A.J.
        • et al.
        Lifetime physical activity and the risk of amyotrophic lateral sclerosis.
        J Neurol Neurosurg Psychiatry. 2013 Sep 1; 84: 976-981
        • Mattsson P.
        • Lönnstedt I.
        • Nygren I.
        • Askmark H.
        Physical fitness, but not muscle strength, is a risk factor for death in amyotrophic lateral sclerosis at an early age.
        J Neurol Neurosurg Psychiatry. 2012 Apr; 83: 390-394
        • McCrate M.E.
        • Kaspar B.K.
        Physical activity and neuroprotection in amyotrophic lateral sclerosis.
        NeuroMolecular Med. 2008 Jun 20; 10: 108-117
        • Barichella M.
        • Cereda E.
        • Pezzoli G.
        Major nutritional issues in the management of Parkinson's disease.
        Mov Disord. 2009 Oct 15; 24: 1881-1892
        • Sheard J.M.
        • Ash S.
        • Mellick G.D.
        • Silburn P.A.
        • Kerr G.K.
        Malnutrition in a sample of community-dwelling people with Parkinson's disease.
        PLoS One. 2013; 8
        • Sharma J.C.
        • Vassallo M.
        Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype.
        Neurodegener Dis Manag. 2014 Aug; 4: 309-316
        • Kistner A.
        • Lhomméee E.
        • Krack P.
        Mechanisms of body weight fluctuations in Parkinson's disease.
        Front Neurol. 2014 Jun 2; 5: 84
        • Aiello M.
        • Eleopra R.
        • Rumiati R.I.
        Body weight and food intake in Parkinson's disease. A review of the association to non-motor symptoms.
        Appetite. 2015 Jan; 84: 204-211
        • van der Marck M.A.
        • Dicke H.C.
        • Uc E.Y.
        • Kentin Z.H.A.
        • Borm G.F.
        • Bloem B.R.
        • et al.
        Body mass index in Parkinson's disease: a meta-analysis.
        Park Relat Disord. 2012 Mar; 18: 263-267
        • Barichella M.
        • Cereda E.
        • Madio C.
        • Iorio L.
        • Pusani C.
        • Cancello R.
        • et al.
        Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.
        Br J Nutr. 2013; 110: 347-353
        • Fasano A.
        • Visanji N.P.
        • Liu L.W.C.
        • Lang A.E.
        • Pfeiffer R.F.
        Gastrointestinal dysfunction in Parkinson's disease.
        Lancet Neurol. 2015; 14: 625-639
        • Şahin-Onat Ş.
        • Kaya K.
        • Özel S.
        Rehabilitation of Parkinson's disease.
        Turk Geriatr Derg. 2009; 12: 36-48
        • Rieu I.
        • Derost P.
        • Ulla M.
        • Marques A.
        • Debilly B.
        • De Chazeron I.
        • et al.
        Body weight gain and deep brain stimulation.
        J Neurol Sci. 2011 Nov 15; 310: 267-270
        • Cereda E.
        • Cassani E.
        • Barichella M.
        • Spadafranca A.
        • Caccialanza R.
        • Bertoli S.
        • et al.
        Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution.
        Clin Nutr. 2012 Oct; 31: 699-704
        • Barichella M.
        • Pinelli G.
        • Iorio L.
        • Cassani E.
        • Valentino A.
        • Pusani C.
        • et al.
        Sarcopenia and dynapenia in patients with Parkinsonism.
        J Am Med Dir Assoc. 2016 Jul 1; 17: 640-646
        • Shen L.
        • Ji H.-F.
        Associations between vitamin D status, supplementation, outdoor work and risk of Parkinson's disease: a meta-analysis assessment.
        Nutrients. 2015 Jun 15; 7: 4817-4827
        • Rimmelzwaan L.M.
        • van Schoor N.M.
        • Lips P.
        • Berendse H.W.
        • Eekhoff E.M.W.
        Systematic review of the relationship between vitamin D and Parkinson's disease.
        J Park Dis. 2016 Mar 30; 6: 29-37
        • Barichella M.
        • Cereda E.
        • Cassani E.
        • Pinelli G.
        • Iorio L.
        • Ferri V.
        • et al.
        Dietary habits and neurological features of Parkinson's disease patients: implications for practice.
        Clin Nutr. 2017 Jul 5; 36: 1054-1061
        • Suzuki M.
        • Yoshioka M.
        • Hashimoto M.
        • Murakami M.
        • Noya M.
        • Takahashi D.
        • et al.
        Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease.
        Am J Clin Nutr. 2013 May 1; 97: 1004-1013
        • van den Bos F.
        • Speelman A.D.
        • Samson M.
        • Munneke M.
        • Bloem B.R.
        • Verhaar H.J.J.
        Parkinson's disease and osteoporosis.
        Age Ageing. 2013 Mar 1; 42: 156-162
        • Sato Y.
        • Manabe S.
        • Kuno H.
        • Oizumi K.
        Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 1999 Jan; 66: 64-68
        • Lee S.H.
        • Kim M.J.
        • Kim B.-J.
        • Kim S.R.
        • Chun S.
        • Ryu J.S.
        • et al.
        Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease.
        Mov Disord. 2010 Feb 15; 25: 332-340
        • Hu X.-W.
        • Qin S.-M.
        • Li D.
        • Hu L.-F.
        • Liu C.-F.
        Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis.
        Acta Neurol Scand. 2013 Aug; 128: 73-82
        • Zesiewicz T.A.
        • Wecker L.
        • Sullivan K.L.
        • Merlin L.R.
        • Hauser R.A.
        The controversy concerning plasma homocysteine in parkinson disease patients treated with levodopa alone or with entacapone.
        Clin Neuropharmacol. 2006 May; 29: 106-111
        • Zoccolella S.
        • Lamberti P.
        • Armenise E.
        • de Mari M.
        • Lamberti S.V.
        • Mastronardi R.
        • et al.
        Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications.
        Park Relat Disord. 2005 Mar; 11: 131-133
        • Triantafyllou N.I.
        • Kararizou E.
        • Angelopoulos E.
        • Tsounis S.
        • Boufidou F.
        • Evangelopoulos M.E.
        • et al.
        The influence of levodopa and the COMT inhibitor on serum vitamin B12 and folate levels in Parkinson's disease patients.
        Eur Neurol. 2007 Jun 12; 58: 96-99
        • Lamberti P.
        • Zoccolella S.
        • Armenise E.
        • Lamberti S.V.
        • Fraddosio A.
        • Mari M.
        • et al.
        Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration.
        Eur J Neurol. 2005 May; 12: 365-368
        • Postuma R.B.
        • Espay A.J.
        • Zadikoff C.
        • Suchowersky O.
        • Martin W.R.W.
        • Lafontaine A.-L.
        • et al.
        Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study.
        Neurology. 2006 Jun 27; 66: 1941-1943
        • Ceravolo R.
        • Cossu G.
        • Bandettini di Poggio M.
        • Santoro L.
        • Barone P.
        • Zibetti M.
        • et al.
        Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
        Mov Disord. 2013 Sep; 28: 1391-1397
        • Mari F.
        • Matei M.
        • Ceravolo M.G.
        • Pisani A.
        • Montesi A.
        • Provinciali L.
        Predictive value of clinical indices in detecting aspiration in patients with neurological disorders.
        J Neurol Neurosurg Psychiatry. 1997; 63: 456-460
        • Etminan M.
        • Gill S.S.
        • Samii A.
        Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis.
        Lancet Neurol. 2005 Jun; 4: 362-365
        • Takeda A.
        • Nyssen O.P.
        • Syed A.
        • Jansen E.
        • Bueno-de-Mesquita B.
        • Gallo V.
        Vitamin A and carotenoids and the risk of Parkinson's disease: a systematic review and meta-analysis.
        Neuroepidemiology. 2014; 42: 25-38
        • Mischley L.K.
        • Allen J.
        • Bradley R.
        Coenzyme Q10 deficiency in patients with Parkinson's disease.
        J Neurol Sci. 2012 Jul 15; 318: 72-75
        • The parkinson study group
        Effect of deprenyl on the progression of disability in early Parkinson's disease.
        N Engl J Med. 1989 Nov 16; 321: 1364-1371
        • Beal M.F.
        • Oakes D.
        • Shoulson I.
        • Henchcliffe C.
        • Galpern W.R.
        • et al.
        • Parkinson Study Group QE3 Investigators
        A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
        JAMA Neurol. 2014 May 1; 71: 543-552
        • Liu J.
        • Wang L.
        • Zhan S.-Y.
        • Xia Y.
        Coenzyme Q10 for Parkinson's disease.
        in: Wang L. Cochrane database of systematic reviews. John Wiley & Sons, Ltd, Chichester, UK2011: CD008150
        • Suttrup I.
        • Warnecke T.
        Dysphagia in Parkinson's disease.
        Dysphagia. 2016; 31: 24-32
        • Takizawa C.
        • Gemmell E.
        • Kenworthy J.
        • Speyer R.
        A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson's disease, Alzheimer's disease, head injury, and pneumonia.
        Dysphagia. 2016 Jun 12; 31: 434-441
        • Lam K.
        • Lam F.K.Y.
        • Kwok K.L.
        • Yiu K.C.
        • Kan E.Y.L.
        • Woo J.
        • et al.
        Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson's disease.
        Mov Disord. 2007; 22: 640-644
        • Cereda E.
        • Cilia R.
        • Klersy C.
        • Canesi M.
        • Zecchinelli A.L.
        • Mariani C.B.
        • et al.
        Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors.
        Park Relat Disord. 2014; 20: 1382-1387
        • Kalf J.G.
        • De Swart B.J.M.
        • Bloem B.R.
        • Munneke M.
        Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis.
        Park Relat Disord. 2012 May; 18: 311-315
        • Bushmann M.
        • Dobmeyer S.M.
        • Leeker L.
        • Perlmutter J.S.
        Swallowing abnormalities and their response to treatment in Parkinson's disease.
        Neurology. 1989 Oct; 39: 1309-1314
        • Bird M.R.
        • Woodward M.C.
        • Gibson E.M.
        • Phyland D.J.
        • Fonda D.
        Asymptomatic swallowing disorders in elderly patients with Parkinson's disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients.
        Age Ageing. 1994 May; 23: 251-254
        • Rodrigues B.
        • Nóbrega A.C.
        • Sampaio M.
        • Argolo N.
        • Melo A.
        Silent saliva aspiration in Parkinson's disease.
        Mov Disord. 2011; 26: 138-141
        • Monteiro L.
        • Souza-Machado A.
        • Pinho P.
        • Sampaio M.
        • Nóbrega A.C.
        • Melo A.
        Swallowing impairment and pulmonary dysfunction in Parkinson's disease: the silent threats.
        J Neurol Sci. 2014; 339: 149-152
        • Wood L.D.
        • Neumiller J.J.
        • Setter S.M.
        • Dobbins E.K.
        Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.
        Am J Geriatr Pharmacother. 2010 Aug; 8: 294-315
        • Lethbridge L.
        • Johnston G.M.
        • Turnbull G.
        Co-morbidities of persons dying of Parkinson's disease.
        Prog Palliat Care. 2013 Jul 15; 21: 140-145
        • Michou E.
        • Hamdy S.
        Dysphagia in Parkinsons disease: a therapeutic challenge?.
        Expert Rev Neurother. 2010; 10: 875-878
        • Simons J.A.
        • Fietzek U.M.
        • Waldmann A.
        • Warnecke T.
        • Schuster T.
        • Ceballos-Baumann A.O.
        Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson's disease.
        Park Relat Disord. 2014 Sep; 20: 992-998
        • Manor Y.
        • Giladi N.
        • Cohen A.
        • Fliss D.M.
        • Cohen J.T.
        Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease.
        Mov Disord. 2007; 22: 1917-1921
        • Potulska A.
        • Friedman A.
        • Królicki L.
        • Spychala A.
        Swallowing disorders in Parkinson's disease.
        Park Relat Disord. 2003; 9: 349-353
        • Belo L.R.
        • Gomes N.A.C.
        • Coriolano M.D.G.W.D.S.
        • De Souza E.S.
        • Moura D.A.A.
        • Asano A.G.
        • et al.
        The relationship between limit of dysphagia and average volume per swallow in patients with Parkinson's disease.
        Dysphagia. 2014; 29: 419-424
        • Ertekin C.
        • Aydoğdu I.
        • Yüceyar N.
        Piecemeal deglutition and dysphagia limit in normal subjects and in patients with swallowing disorders.
        J Neurol Neurosurg Psychiatry. 1996 Nov; 61: 491-496
        • Clarke C.E.
        • Gullaksen E.
        • Macdonald S.
        • Lowe F.
        Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson's disease.
        Acta Neurol Scand. 1998 Jan; 97: 27-35
        • Miller N.
        • Allcock L.
        • Hildreth A.J.
        • Jones D.
        • Noble E.
        • Burn D.J.
        Swallowing problems in Parkinson disease: frequency and clinical correlates.
        J Neurol Neurosurg Psychiatry. 2009 Sep 1; 80: 1047-1049
        • Kanna S.V.
        • Bhanu K.
        A simple bedside test to assess the swallowing dysfunction in Parkinson's disease.
        Ann Indian Acad Neurol. 2014 Jan; 17: 62-65
        • Nóbrega A.C.
        • Rodrigues B.
        • Melo A.
        Is silent aspiration a risk factor for respiratory infection in Parkinson's disease patients?.
        Park Relat Disord. 2008; 14: 646-648
        • Nóbrega A.C.
        • Rodrigues B.
        • Melo A.
        Silent aspiration in Parkinson's disease patients with diurnal sialorrhea.
        Clin Neurol Neurosurg. 2008 Feb; 110: 117-119
        • Carnaby-Mann G.
        • Lenius K.
        The bedside examination in dysphagia.
        Phys Med Rehabil Clin N Am. 2008 Nov; 19 (viii): 747-768
        • Warnecke T.
        • Hamacher C.
        • Oelenberg S.
        • Dziewas R.
        Off and on state assessment of swallowing function in Parkinson's disease.
        Park Relat Disord. 2014 Sep; 20: 1033-1034
        • Monte F.S.
        • da Silva-Júnior F.P.
        • Braga-Neto P.
        • Nobre e Souza M.Â.
        • Sales de Bruin V.M.
        Swallowing abnormalities and dyskinesia in Parkinson's disease.
        Mov Disord. 2005 Apr; 20: 457-462
        • Baijens L.W.J.
        • Speyer R.
        • Passos V.L.
        • Pilz W.
        • Roodenburg N.
        • Clave P.
        Swallowing in Parkinson patients versus healthy controls: reliability of measurements in videofluoroscopy.
        Gastroenterol Res Pract. 2011; 2011: 380682
        • Manor Y.
        • Mootanah R.
        • Freud D.
        • Giladi N.
        • Cohen J.T.
        Video-assisted swallowing therapy for patients with Parkinson's disease.
        Park Relat Disord. 2013 Feb; 19: 207-211
        • Sung H.-Y.
        • Choi M.-G.
        • Kim J.-S.
        The prevalence and patterns of oesophageal dysmotility in patients with Parkinson's disease.
        Eur J Neurol. 2009; 16: 555
        • Ryu J.S.
        • Park D.H.
        • Kang J.Y.
        Application and interpretation of high-resolution manometry for pharyngeal dysphagia.
        J Neurogastroenterol Motil. 2015 Mar 30; 21: 283-287
        • Omari T.I.
        • Papathanasopoulos A.
        • Dejaeger E.
        • Wauters L.
        • Scarpellini E.
        • Vos R.
        • et al.
        Reproducibility and agreement of pharyngeal automated impedance manometry with videofluoroscopy.
        Clin Gastroenterol Hepatol. 2011 Oct; 9: 862-867
        • Omari T.I.
        • Dejaeger E.
        • van Beckevoort D.
        • Goeleven A.
        • Davidson G.P.
        • Dent J.
        • et al.
        A method to objectively assess swallow function in adults with suspected aspiration.
        Gastroenterology. 2011 May; 140: 1454-1463
        • Omari T.I.
        • Dejaeger E.
        • Tack J.
        • Vanbeckevoort D.
        • Rommel N.
        An impedance-manometry based method for non-radiological detection of pharyngeal postswallow residue.
        Neurogastroenterol Motil. 2012 Jul; 24: e277-e284
        • Santos K.
        • Scheeren B.
        • Maciel A.
        • Cassol M.
        Vocal variability post swallowing in individuals with and without oropharyngeal dysphagia.
        Int Arch Otorhinolaryngol. 2014 Oct 17; 19: 061-066
        • Van Hooren M.R.A.
        • Baijens L.W.J.
        • Vos R.
        • Pilz W.
        • Kuijpers L.M.F.
        • Kremer B.
        • et al.
        Voice- and swallow-related quality of life in idiopathic Parkinson's disease.
        Laryngoscope. 2016 Feb; 126: 408-414
        • Waito A.
        • Bailey G.L.
        • Molfenter S.M.
        • Zoratto D.C.
        • Steele C.M.
        Voice-quality abnormalities as a sign of dysphagia: validation against acoustic and videofluoroscopic data.
        Dysphagia. 2011 Jun 8; 26: 125-134
        • Sarraf Shirazi S.
        • Birjandi A.H.
        • Moussavi Z.
        Noninvasive and automatic diagnosis of patients at high risk of swallowing aspiration.
        Med Biol Eng Comput. 2014 May 25; 52: 459-465
        • Sarraf Shirazi S.
        • Buchel C.
        • Daun R.
        • Lenton L.
        • Moussavi Z.
        Detection of swallows with silent aspiration using swallowing and breath sound analysis.
        Med Biol Eng Comput. 2012 Dec 13; 50: 1261-1268
        • Shirazi S.S.
        • Moussavi Z.
        Silent aspiration detection by breath and swallowing sound analysis.
        in: 2012 annual international conference of the IEEE engineering in medicine and biology society. IEEE, 2012: 2599-2602
        • WS Coriolano M das
        • R Belo L.
        • Carneiro D.
        • G Asano A.
        • AL Oliveira P.J.
        • da Silva D.M.
        • et al.
        Swallowing in patients with Parkinson's disease: a surface electromyography study.
        Dysphagia. 2012 Dec 27; 27: 550-555
        • Schultheiss C.
        • Schauer T.
        • Nahrstaedt H.
        • Seidl R.O.
        Evaluation of an EMG bioimpedance measurement system for recording and analysing the pharyngeal phase of swallowing.
        Eur Arch Otorhinolaryngol. 2013 Jul 26; 270: 2149-2156
        • Gross R.D.
        • Atwood Jr., C.W.
        • Ross S.B.
        • Eichhorn K.A.
        • Olszewski J.W.
        • Doyle P.J.
        The coordination of breathing and swallowing in Parkinson's disease.
        Dysphagia. 2008; 23: 136-145
        • Alfonsi E.
        • Versino M.
        • Merlo I.M.
        • Pacchetti C.
        • Martignoni E.
        • Bertino G.
        • et al.
        Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes.
        Neurology. 2007 Feb 20; 68: 583-589
        • Lafer M.
        • Achlatis S.
        • Lazarus C.
        • Fang Y.
        • Branski R.C.
        • Amin M.R.
        Temporal measurements of deglutition in dynamic magnetic resonance imaging versus videofluoroscopy.
        Ann Otol Rhinol Laryngol. 2013 Dec; 122: 748-753
        • Vijay Kumar K.V.
        • Shankar V.
        • Santosham R.
        Assessment of swallowing and its disorders-a dynamic MRI study.
        Eur J Radiol. 2013 Feb; 82: 215-219
        • Menezes C.
        • Melo A.
        Does levodopa improve swallowing dysfunction in Parkinson's disease patients?.
        J Clin Pharm Ther. 2009 Dec; 34: 673-676
        • Baijens L.W.J.
        • Speyer R.
        Effects of therapy for dysphagia in Parkinson's disease: systematic review.
        Dysphagia. 2009 Mar 18; 24: 91-102
        • Sutton J.P.
        Dysphagia in Parkinson's disease is responsive to levodopa.
        Park Relat Disord. 2013; 19: 282-284
        • Lim A.
        • Leow L.
        • Huckabee M.-L.
        • Frampton C.
        • Anderson T.
        A pilot study of respiration and swallowing integration in Parkinson's disease: “On” and “Off” levodopa.
        Dysphagia. 2008; 23: 76-81
        • Hunter P.C.
        • Crameri J.
        • Austin S.
        • Woodward M.C.
        • Hughes A.J.
        Response of parkinsonian swallowing dysfunction to dopaminergic stimulation.
        J Neurol Neurosurg Psychiatry. 1997 Nov; 63: 579-583
        • Müller B.
        • Assmus J.
        • Larsen J.P.
        • Haugarvoll K.
        • Skeie G.O.
        • Tysnes O.-B.
        • et al.
        Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease.
        Acta Neurol Scand. 2013 Apr; 127: 290-294
        • Grosset D.G.
        • Macphee G.J.A.
        • Nairn M.
        Guideline Development Group. Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines.
        BMJ. 2010 Jan 12; 340: b5614
        • Gilhus Nils Erik
        • Barnes Michael P.
        • Brainin Michael
        European handbook of neurological management.
        Wiley-Blackwell, 2011
        • Pahwa R.
        • Factor S.A.
        • Lyons K.E.
        • Ondo W.G.
        • Gronseth G.
        • Bronte-Stewart H.
        • et al.
        Practice parameter: treatment of parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the quality standards subcommittee of the american Academy of Neurology.
        Neurology. 2006 Apr 11; 66: 983-995
        • Beyer P.L.
        • Palarino M.Y.
        • Michalek D.
        • Busenbark K.
        • Koller W.C.
        Weight change and body composition in patients with Parkinson's disease.
        J Am Diet Assoc. 1995 Sep; 95: 979-983
        • Laudisio A.
        • Vetrano D.L.
        • Meloni E.
        • Ricciardi D.
        • Franceschi F.
        • Bentivoglio A.R.
        • et al.
        Dopaminergic agents and nutritional status in Parkinson's disease.
        Mov Disord. 2014 Oct; 29: 1543-1547
        • Palhagen S.
        • Lorefalt B.
        • Carlsson M.
        • Ganowiak W.
        • Toss G.
        • Unosson M.
        • et al.
        Does l-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?.
        Acta Neurol Scand. 2005 Jan; 111: 12-20
        • Bachmann C.G.
        • Zapf A.
        • Brunner E.
        • Trenkwalder C.
        Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias.
        Eur J Neurol. 2009 Aug; 16: 895-901
        • Adams F.
        • Boschmann M.
        • Lobsien E.
        • Kupsch A.
        • Lipp A.
        • Franke G.
        • et al.
        Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.
        Eur J Clin Pharmacol. 2008 Sep 30; 64: 863-870
        • Vardi J.
        • Oberman Z.
        • Rabey I.
        • Streifler M.
        • Ayalon D.
        • Herzberg M.
        Weight loss in patients treated long-term with levodopa. Metabolic aspects.
        J Neurol Sci. 1976 Nov; 30: 33-40
        • Perlemoine C.
        • Macia F.
        • Tison F.
        • Coman I.
        • Guehl D.
        • Burbaud P.
        • et al.
        Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease.
        Br J Nutr. 2005 Feb; 93: 191-198
        • Miller J.W.
        • Selhub J.
        • Nadeau M.R.
        • Thomas C.A.
        • Feldman R.G.
        • Wolf P.A.
        Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.
        Neurology. 2003 Apr 8; 60: 1125-1129
        • Rogers J.D.
        • Sanchez-Saffon A.
        • Frol A.B.
        • Diaz-Arrastia R.
        Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
        Arch Neurol. 2003 Jan; 60: 59-64
        • Siniscalchi A.
        • Mancuso F.
        • Gallelli L.
        • Ferreri Ibbadu G.
        • Biagio Mercuri N.
        • De Sarro G.
        Increase in plasma homocysteine levels induced by drug treatments in neurologic patients.
        Pharmacol Res. 2005 Nov; 52: 367-375
        • Zoccolella S.
        • Iliceto G.
        • deMari M.
        • Livrea P.
        • Lamberti P.
        Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.
        Clin Chem Lab Med. 2007 Jan 1; 45: 1607-1613
        • Deane K.H.O.
        • Ellis-Hill C.
        • Jones D.
        • Whurr R.
        • Ben-Shlomo Y.
        • Playford E.D.
        • et al.
        Systematic review of paramedical therapies for Parkinson's disease.
        Mov Disord. 2002; 17: 984-991
        • Baijens L.W.J.
        • Speyer R.
        Effects of therapy for dysphagia in parkinson's disease: systematic review.
        Dysphagia. 2009; 24: 91-102
        • van Hooren M.R.A.R.A.
        • Baijens L.W.J.W.J.
        • Voskuilen S.
        • Oosterloo M.
        • Kremer B.
        Treatment effects for dysphagia in Parkinson's disease: a systematic review.
        Park Relat Disord. 2014 Aug; 20: 800-807
        • Smith S.K.
        • Roddam H.
        • Sheldrick H.
        Rehabilitation or compensation: time for a fresh perspective on speech and language therapy for dysphagia and Parkinson's disease?.
        Int J Lang Commun Disord. 2012 Jul; 47: 351-364
        • Troche M.S.
        • Sapienza C.M.
        • Rosenbek J.C.
        Effects of bolus consistency on timing and safety of swallow in patients with Parkinson's disease.
        Dysphagia. 2008 Mar 6; 23: 26-32
        • Logemann J.A.
        • Gensler G.
        • Robbins J.
        • Lindblad A.S.
        • Brandt D.
        • Hind J.A.
        • et al.
        A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease.
        J Speech, Lang Hear Res. 2008 Feb 1; 51: 173-183
        • Robbins J.
        • Gensler G.
        • Hind J.
        • Logemann J.A.
        • Lindblad A.S.
        • Brandt D.
        • et al.
        Comparison of 2 interventions for liquid aspiration on pneumonia incidence: a randomized trial.
        Ann Intern Med. 2008; 148: 509-518
        • Pitts T.
        • Bolser D.
        • Rosenbek J.
        • Troche M.
        • Okun M.S.
        • Sapienza C.
        Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease.
        Chest. 2009 May 1; 135: 1301-1308
        • Troche M.S.
        • Okun M.S.
        • Rosenbek J.C.
        • Musson N.
        • Fernandez H.H.
        • Rodriguez R.
        • et al.
        Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial.
        Neurology. 2010; 75: 1912-1919
        • Argolo N.
        • Sampaio M.
        • Pinho P.
        • Melo A.
        • Nóbrega A.C.
        Do swallowing exercises improve swallowing dynamic and quality of life in Parkinson's disease?.
        NeuroRehabilitation. 2013; 32: 949-955
        • El Sharkawi A.
        • Ramig L.
        • Logemann J.A.
        • Pauloski B.R.
        • Rademaker A.W.
        • Smith C.H.
        • et al.
        Swallowing and voice effects of lee silverman voice treatment (LSVT®): a pilot study.
        J Neurol Neurosurg Psychiatry. 2002 Jan; 72: 31-36
        • Regan J.
        • Walshe M.
        • Tobin W.O.
        Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic parkinson's disease.
        Dysphagia. 2010; 25: 207-215
        • Baijens L.W.J.
        • Speyer R.
        • Passos V.L.
        • Pilz W.
        • Van Der Kruis J.
        • Haarmans S.
        • et al.
        Surface electrical stimulation in dysphagic Parkinson patients: a randomized clinical trial.
        Dysphagia. 2013 Nov; 123: E38-E44
        • Heijnen B.J.
        • Speyer R.
        • Baijens L.W.J.
        • Bogaardt H.C.A.
        Neuromuscular electrical stimulation versus traditional therapy in patients with parkinson's disease and oropharyngeal dysphagia: effects on quality of life.
        Dysphagia. 2012 Sep 13; 27: 336-345
        • Barwood C.H.S.
        • Murdoch B.E.
        rTMS as a treatment for neurogenic communication and swallowing disorders.
        Acta Neurol Scand. 2013; 127: 77-91
        • Cereda E.
        • Barichella M.
        • Pedrolli C.
        • Pezzoli G.
        Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review.
        Mov Disord. 2010 Oct 15; 25: 2021-2034
        • Olanow C.W.
        • Watts R.L.
        • Koller W.C.
        An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.
        Neurology. 2001 Jun; 56: S1-S88
        • Barichella M.
        • Marczewska A.
        • De Notaris R.
        • Vairo A.
        • Baldo C.
        • Mauri A.
        • et al.
        Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease.
        Mov Disord. 2006 Oct; 21: 1682-1687
        • Cereda E.
        • Pezzoli G.
        • Barichella M.
        Role of an electronic armband in motor function monitoring in patients with Parkinson's disease.
        Nutrition. 2010 Feb; 26: 240-242
        • Deutz N.E.P.
        • Bauer J.M.
        • Barazzoni R.
        • Biolo G.
        • Boirie Y.
        • Bosy-Westphal A.
        • et al.
        Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group.
        Clin Nutr. 2014 Dec; 33: 929-936
        • Baroni L.
        • Bonetto C.
        • Tessan F.
        • Goldin D.
        • Cenci L.
        • Magnanini P.
        • et al.
        Pilot dietary study with normoproteic protein-redistributed plant-food diet and motor performance in patients with Parkinson's disease.
        Nutr Neurosci. 2011 Jan 19; 14: 1-9
        • Sheard J.M.
        • Ash S.
        • Mellick G.D.
        • Silburn P.A.
        • Kerr G.K.
        Improved nutritional status is related to improved quality of life in Parkinson's disease.
        BMC Neurol. 2014 Nov 18; 14: 212
        • Fereshtehnejad S.-M.
        • Ghazi L.
        • Shafieesabet M.
        • Shahidi G.A.
        • Delbari A.
        • Lökk J.
        Motor, psychiatric and fatigue features associated with nutritional status and its effects on quality of life in Parkinson's disease patients.
        PLoS One. 2014 Mar 7; 9: e91153
        • Bender A.
        • Koch W.
        • Elstner M.
        • Schombacher Y.
        • Bender J.
        • Moeschl M.
        • et al.
        Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
        Neurology. 2006 Oct 10; 67: 1262-1264
        • Weber C.A.
        • Ernst M.E.
        Antioxidants, supplements, and Parkinson's disease.
        Ann Pharmacother. 2006 May 2; 40: 935-938
        • Rossi M.
        • Merello M.
        • Perez-Lloret S.
        Management of constipation in Parkinson's disease.
        Expert Opin Pharmacother. 2015 Mar 4; 16: 547-557
        • Bharucha A.E.
        • Pemberton J.H.
        • Locke G.R.
        American Gastroenterological Association technical review on constipation.
        Gastroenterology. 2013 Jan; 144: 218-238
        • Ashraf W.
        • Pfeiffer R.F.
        • Park F.
        • Lof J.
        • Quigley E.M.
        Constipation in Parkinson's disease: objective assessment and response to psyllium.
        Mov Disord. 1997 Nov; 12: 946-951
        • Cassani E.
        • Privitera G.
        • Pezzoli G.
        • Pusani C.
        • Madio C.
        • Iorio L.
        • et al.
        Use of probiotics for the treatment of constipation in Parkinson's disease patients.
        Minerva Gastroenterol Dietol. 2011 Jun; 57: 117-121
        • Barichella M.
        • Pacchetti C.
        • Bolliri C.
        • Cassani E.
        • Iorio L.
        • Pusani C.
        • et al.
        Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT.
        Neurology. 2016 Sep 20; 87: 1274-1280
        • Pasquinelli S.
        • Solaro C.
        Nutritional assessment and malnutrition in multiple sclerosis.
        Neurol Sci. 2008 Dec 16; 29: S367-S369
        • Poorjavad M.
        • Derakhshandeh F.
        • Etemadifar M.
        • Soleymani B.
        • Minagar A.
        • Maghzi A.-H.
        Oropharyngeal dysphagia in multiple sclerosis.
        Mult Scler. 2010 Mar 1; 16: 362-365
        • Schwarz S.
        • Leweling H.
        Multiple sclerosis and nutrition.
        Mult Scler. 2005 Feb; 11: 24-32
        • Habek M.
        • Hojsak I.
        • Brinar V.V.
        Nutrition in multiple sclerosis.
        Clin Neurol Neurosurg. 2010 Sep; 112: 616-620
        • Swank R.L.
        Multiple sclerosis; a correlation of its incidence with dietary fat.
        Am J Med Sci. 1950 Oct; 220: 421-430
        • Swank R.L.
        • Lerstad O.
        • Strøm A.
        • Backer J.
        Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition.
        N Engl J Med. 1952 May 8; 246: 722-728
        • Ruxton C.H.S.
        • Calder P.C.
        • Reed S.C.
        • Simpson M.J.A.
        The impact of long-chain n-3 polyunsaturated fatty acids on human health.
        Nutr Res Rev. 2005 Jun 10; 18: 113
        • Hoare S.
        • Lithander F.
        • van der Mei I.
        • Ponsonby A.-L.
        • Lucas R.
        • Ausimmune Investigator Group C.
        • et al.
        Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the Ausimmune Study.
        Mult Scler. 2016 Jun 1; 22: 884-892
        • Torkildsen O.
        • Wergeland S.
        • Bakke S.
        • Beiske A.G.
        • Bjerve K.S.
        • Hovdal H.
        • et al.
        ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.
        Arch Neurol. 2012 Aug 1; 69: 1044-1051
        • Schmitz K.
        • Barthelmes J.
        • Stolz L.
        • Beyer S.
        • Diehl O.
        • Tegeder I.
        Disease modifying nutricals” for multiple sclerosis.
        Pharmacol Ther. 2015 Apr; 148: 85-113
        • Pozuelo-Moyano B.
        • Benito-León J.
        Diet and multiple sclerosis.
        Rev Neurol. 2014 May 16; 58: 455-464
        • van der Mei I.A.
        • Ponsonby A.L.
        • Blizzard L.
        • Dwyer T.
        Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation.
        Neuroepidemiology. 2001 Aug; 20: 168-174
        • Staples J.
        • Ponsonby A.-L.
        • Lim L.
        Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
        BMJ. 2010 Apr 29; 340: c1640
        • Munger K.L.
        • Levin L.I.
        • Hollis B.W.
        • Howard N.S.
        • Ascherio A.
        Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
        JAMA. 2006 Dec 20; 296: 2832
        • Compston A.
        • Coles A.
        Multiple sclerosis.
        Lancet. 2008 Oct 25; 372: 1502-1517
        • Munger K.L.
        • Ascherio A.
        Prevention and treatment of MS: studying the effects of vitamin D.
        Mult Scler J. 2011 Dec 1; 17: 1405-1411
        • Wade D.T.
        • Young C.A.
        • Chaudhuri K.R.
        • Davidson D.L.W.
        A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis.
        J Neurol Neurosurg Psychiatry. 2002 Sep; 73: 246-249
        • Lange L.S.
        • Shiner M.
        • Bateson M.C.
        • Hopwood D.
        • MacGillivray J.B.
        • Lange L.S.
        • et al.
        Jejunal morphology in multiple sclerosis.
        Lancet (London, England). 1979 Jun 16; 1: 1300-1301
        • Hadjivassiliou M.
        • Gibson A.
        • Davies-Jones G.A.
        • Lobo A.J.
        • Stephenson T.J.
        • Milford-Ward A.
        Does cryptic gluten sensitivity play a part in neurological illness?.
        Lancet (London, England). 1996 Feb 10; 347: 369-371
        • Hunter A.L.
        • Rees B.W.
        • Jones L.T.
        Gluten antibodies in patients with multiple sclerosis.
        Hum Nutr Appl Nutr. 1984 Apr; 38: 142-143
        • Hewson D.C.
        Is there a role for gluten-free diets in multiple sclerosis?.
        Hum Nutr Appl Nutr. 1984 Dec; 38: 417-420
        • Wortsman J.
        • Matsuoka L.Y.
        • Chen T.C.
        • Lu Z.
        • Holick M.F.
        Decreased bioavailability of vitamin D in obesity.
        Am J Clin Nutr. 2000 Sep; 72: 690-693
        • Parikh S.J.
        • Edelman M.
        • Uwaifo G.I.
        • Freedman R.J.
        • Semega-Janneh M.
        • Reynolds J.
        • et al.
        The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults.
        J Clin Endocrinol Metab. 2004 Mar; 89: 1196-1199
        • Munger K.L.
        • Chitnis T.
        • Ascherio A.
        Body size and risk of MS in two cohorts of US women.
        Neurology. 2009 Nov 10; 73: 1543-1550
        • Simon K.C.
        • Munger K.L.
        • Ascherio A.
        XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?.
        J Neurol Sci. 2011 Dec 15; 311: 1-8
        • Hedstrom A.K.
        • Olsson T.
        • Alfredsson L.
        High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women.
        Mult Scler J. 2012 Sep 1; 18: 1334-1336
        • Munger K.L.
        • Zhang S.M.
        • O'Reilly E.
        • Hernán M.A.
        • Olek M.J.
        • Willett W.C.
        • et al.
        Vitamin D intake and incidence of multiple sclerosis.
        Neurology. 2004 Jan 13; 62: 60-65
        • Ascherio A.
        • Munger K.L.
        • White R.
        • Köchert K.
        • Simon K.C.
        • Polman C.H.
        • et al.
        Vitamin D as an early predictor of multiple sclerosis activity and progression.
        JAMA Neurol. 2014 Mar 1; 71: 306-314
        • Ascherio A.
        • Munger K.L.
        • Simon K.C.
        Vitamin D and multiple sclerosis.
        Lancet Neurol. 2010 Jun; 9: 599-612
        • Kampman M.T.
        • Steffensen L.H.
        The role of vitamin D in multiple sclerosis.
        J Photochem Photobiol B. 2010 Nov 3; 101: 137-141
        • Multiple Sclerosis
        Management of multiple sclerosis in primary and secondary care - PubMed - NCBI [internet].
        National Institute for Health and Care Excellence (UK); London, London2014 ([cited 2017 Jan 1]. Available from:)
      2. Vitamin D for the treatment or prevention of multiple sclerosis: a review of the clinical effectiveness. Canadian Agency for Drugs and Technologies in Health, 2016
        • Shaygannejad V.
        • Janghorbani M.
        • Ashtari F.
        • Dehghan H.
        Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
        Mult Scler Int. 2012; 2012: 452541
        • Burton J.M.
        • Kimball S.
        • Vieth R.
        • Bar-Or A.
        • Dosch H.-M.
        • Cheung R.
        • et al.
        A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.
        Neurology. 2010 Jun 8; 74: 1852-1859
        • Kampman M.T.
        • Steffensen L.H.
        • Mellgren S.I.
        • Jørgensen L.
        Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
        Mult Scler. 2012 Aug 1; 18: 1144-1151
        • Soilu-Hänninen M.
        • Aivo J.
        • Lindström B.-M.
        • Elovaara I.
        • Sumelahti M.-L.
        • Färkkilä M.
        • et al.
        A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
        J Neurol Neurosurg Psychiatry. 2012 May; 83: 565-571
        • Stein M.S.
        • Liu Y.
        • Gray O.M.
        • Baker J.E.
        • Kolbe S.C.
        • Ditchfield M.R.
        • et al.
        A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
        Neurology. 2011 Oct 25; 77: 1611-1618
        • Golan D.
        • Halhal B.
        • Glass-Marmor L.
        • Staun-Ram E.
        • Rozenberg O.
        • Lavi I.
        • et al.
        Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.
        BMC Neurol. 2013 Jun 14; 13: 60
        • Autier P.
        • Boniol M.
        • Pizot C.
        • Mullie P.
        Vitamin D status and ill health: a systematic review.
        lancet Diabetes Endocrinol. 2014 Jan; 2: 76-89
        • James E.
        • Dobson R.
        • Kuhle J.
        • Baker D.
        • Giovannoni G.
        • Ramagopalan S.V.
        The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.
        Mult Scler. 2013 Oct 1; 19: 1571-1579
        • Mehta L.R.
        • Dworkin R.H.
        • Schwid S.R.
        Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis.
        Nat Clin Pract Neurol. 2009 Feb; 5: 82-92
        • Dworkin R.H.
        • Bates D.
        • Millar J.H.
        • Paty D.W.
        Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials.
        Neurology. 1984 Nov; 34: 1441-1445
        • Farinotti M.
        • Vacchi L.
        • Simi S.
        • Di Pietrantonj C.
        • Brait L.
        • Filippini G.
        Dietary interventions for multiple sclerosis.
        in: Farinotti M. Cochrane database of systematic reviews. John Wiley & Sons, Ltd, Chichester, UK2012: CD004192
        • Bates D.
        • Cartlidge N.E.
        • French J.M.
        • Jackson M.J.
        • Nightingale S.
        • Shaw D.A.
        • et al.
        A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.
        J Neurol Neurosurg Psychiatry. 1989 Jan; 52: 18-22
        • Payne A.
        Nutrition and diet in the clinical management of multiple sclerosis.
        J Hum Nutr Diet. 2001 Oct; 14: 349-357
        • Sorgun M.H.
        • Yucesan C.
        • Tegin C.
        Is malnutrition a problem for multiple sclerosis patients?.
        J Clin Neurosci. 2014 Sep; 21: 1603-1605
        • Payne C.
        • Wiffen P.J.
        • Martin S.
        Interventions for fatigue and weight loss in adults with advanced progressive illness.
        in: Cochrane database syst rev. vol. 1. 2012 Jan 18: CD008427
        • Baldwin C.
        • Weekes C.E.
        Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults.
        in: Baldwin C. Cochrane database of systematic reviews. John Wiley & Sons, Ltd, Chichester, UK2011: CD002008
        • Baldwin C.
        • Weekes C.E.
        Dietary advice for illness-related malnutrition in adults.
        in: Cochrane database syst rev. vol. 23;(1). 2008 Jan: CD002008
        • Baldwin C.
        • Weekes C.E.
        Dietary counselling with or without oral nutritional supplements in the management of malnourished patients: a systematic review and meta-analysis of randomised controlled trials.
        J Hum Nutr Diet. 2012 Oct; 25: 411-426
        • Cawood A.L.
        • Elia M.
        • Stratton R.J.
        Systematic review and meta-analysis of the effects of high protein oral nutritional supplements.
        Ageing Res Rev. 2012 Apr; 11: 278-296
        • Elia M.
        • Normand C.
        • Laviano A.
        • Norman K.
        A systematic review of the cost and cost effectiveness of using standard oral nutritional supplements in community and care home settings.
        Clin Nutr. 2016 Feb; 35: 125-137
        • Stratton R.J.
        • Elia M.
        Encouraging appropriate, evidence-based use of oral nutritional supplements.
        Proc Nutr Soc. 2010 Nov 10; 69: 477-487
        • Chruzander C.
        • Johansson S.
        • Gottberg K.
        • Einarsson U.
        • Fredrikson S.
        • Holmqvist L.W.
        • et al.
        A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in disability and the value of different factors in predicting disability and mortality.
        J Neurol Sci. 2013 Sep 15; 332: 121-127
        • Kingwell E.
        • van der Kop M.
        • Zhao Y.
        • Shirani A.
        • Zhu F.
        • Oger J.
        • et al.
        Relative mortality and survival in multiple sclerosis: findings from British Columbia.
        Can J Neurol Neurosurg Psychiatry. 2012 Jan; 83: 61-66
        • Scalfari A.
        • Knappertz V.
        • Cutter G.
        • Goodin D.S.
        • Ashton R.
        • Ebers G.C.
        Mortality in patients with multiple sclerosis.
        Neurology. 2013 Jul 9; 81: 184-192
        • Rodríguez-Antigüedad Zarranz A.
        • Mendibe Bilbao M.
        • Llarena González C.
        • Audicana C.
        Mortality and cause of death in multiple sclerosis: findings from a prospective population-based cohort in Bizkaia, Basque Country, Spain.
        Neuroepidemiology. 2014; 42: 219-225
        • De Pauw A.
        • Dejaeger E.
        • D’hooghe B.
        • Carton H.
        Dysphagia in multiple sclerosis.
        Clin Neurol Neurosurg. 2002 Sep; 104: 345-351
        • Tassorelli C.
        • Bergamaschi R.
        • Buscone S.
        • Bartolo M.
        • Furnari A.
        • Crivelli P.
        • et al.
        Dysphagia in multiple sclerosis: from pathogenesis to diagnosis.
        Neurol Sci. 2008 Dec 16; 29: 360-363
        • Abraham Suzanne
        • Scheinberg LabeC.
        • Smith Charles R.
        • LaRocca Nicholas G.
        Neurologic impairment and disability status in outpatients with multiple sclerosis reporting dysphagia symptomatology.
        J Neuro Rehab. 1997; 11: 7-13
        • Bergamaschi R.
        • Crivelli P.
        • Rezzani C.
        • Patti F.
        • Solaro C.
        • Rossi P.
        • et al.
        The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
        J Neurol Sci. 2008 Jun 15; 269: 49-53
        • Bergamaschi R.
        • Rezzani C.
        • Minguzzi S.
        • Amato M.P.
        • Patti F.
        • Marrosu M.G.
        • et al.
        Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
        Funct Neurol. 2009; 24: 159-162
        • Solaro C.
        • Rezzani C.
        • Trabucco E.
        • Amato M.P.
        • Zipoli V.
        • Portaccio E.
        • et al.
        Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire).
        J Neurol Sci. 2013 Aug 15; 331: 94-97
        • Alfonsi E.
        • Bergamaschi R.
        • Cosentino G.
        • Ponzio M.
        • Montomoli C.
        • RD
        Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
        Clin Neurophysiol. 2013; 124: 1638-1645
        • Levinthal D.J.
        • Rahman A.
        • Nusrat S.
        • O'Leary M.
        • Heyman R.
        • Bielefeldt K.
        • et al.
        Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
        Mult Scler Int. 2013; 2013: 319201
        • Thomas F.J.
        • Wiles C.M.
        Dysphagia and nutritional status in multiple sclerosis.
        J Neurol. 1999 Aug; 246: 677-682
        • Fernandes A.M.F.
        • Duprat A de C.
        • Eckley C.A.
        • da Silva L.
        • Ferreira R.B.
        • Tilbery C.P.
        Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?.
        Braz J Otorhinolaryngol. 2013 Aug; 79: 460-465
        • Wiesner W.
        • Wetzel S.G.
        • Kappos L.
        • Hoshi M.M.
        • Witte U.
        • Radue E.W.
        • et al.
        Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms.
        Eur Radiol. 2002 Apr 5; 12: 789-792
        • Terré-Boliart R.
        • Orient-López F.
        • Guevara-Espinosa D.
        • Ramón-Rona S.
        • Bernabeu-Guitart M.
        • Clavé-Civit P.
        Oropharyngeal dysphagia in patients with multiple sclerosis.
        Rev Neurol. 2004; 39: 707-710
        • Beckmann Y.
        • Gürgör N.
        • Çakır A.
        • Arıcı Ş.
        • İncesu T.K.
        • Seçil Y.
        • et al.
        Electrophysiological evaluation of dysphagia in the mild or moderate patients with multiple sclerosis: a concept of subclinical dysphagia.
        Dysphagia. 2015 Jun 17; 30: 296-303
        • Giusti A.
        • Giambuzzi M.
        Management of dysphagia in patients affected by multiple sclerosis: state of the art.
        Neurol Sci. 2008 Dec 16; 29: S364-S366
        • Prosiegel M.
        • Schelling A.
        • Wagner-Sonntag E.
        Dysphagia and multiple sclerosis.
        Int MS J. 2004 Apr; 11: 22-31
        • Kesselring J.
        • Beer S.
        Symptomatic therapy and neurorehabilitation in multiple sclerosis.
        Lancet Neurol. 2005 Oct; 4: 643-652
        • Leder S.B.
        • Judson B.L.
        • Sliwinski E.
        • Madson L.
        Promoting safe swallowing when puree is swallowed without aspiration but thin liquid is aspirated: nectar is enough.
        Dysphagia. 2013 Mar 27; 28: 58-62
        • de Luis D.A.
        • Izaola O.
        • de la Fuente B.
        • Muñoz-Calero P.
        • Franco-Lopez A.
        Neurodegenerative diseases; nutritional aspects.
        Nutr Hosp. 2015 Aug 1; 32: 946-951
        • Cristian D.
        • Poalelungi A.
        • Anghel A.
        • Burcoş T.
        • Grigore R.
        • Berteşteanu S.
        • et al.
        Prophylactic percutaneous endoscopic gastrostomy (PEG) - the importance of nutritonal support in patients with head and neck cancers (HNCs) or neurogenic dysphagia (ND).
        Chir (Bucur). 2015; 110: 129-136
        • Gencosmanoglu R.
        Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions.
        Neurocrit Care. 2004; 1: 309-317
        • Zalar A.E.
        • Guédon C.
        • Piskorz E.L.
        • Sánchez Basso A.
        • Ducrotté P.
        Percutaneous endoscopic gastrostomy in patients with neurological diseases. Results of a prospective multicenter and international study.
        Acta Gastroenterol Latinoam. 2004; 34: 127-132
        • Truelsen T.
        • Piechowski-Jóźwiak B.
        • Bonita R.
        • Mathers C.
        • Bogousslavsky J.
        • Boysen G.
        Stroke incidence and prevalence in Europe: a review of available data.
        Eur J Neurol. 2006 Jun; 13: 581-598
        • Olesen J.
        • Gustavsson A.
        • Svensson M.
        • Wittchen H.-U.
        • Jönsson B.
        • CDBE2010 study group
        • et al.
        The economic cost of brain disorders in Europe.
        Eur J Neurol. 2012 Jan; 19: 155-162
        • Gomes F.
        • Emery P.W.
        • Weekes C.E.
        Risk of malnutrition is an independent predictor of mortality, length of hospital stay, and hospitalization costs in stroke patients.
        J Stroke Cerebrovasc Dis. 2016 Apr; 25: 799-806
        • Dennis M.
        • FOOD Trial Collaboration
        Poor nutritional status on admission predicts poor outcomes after stroke observational data from the food trial.
        Stroke. 2003 Jun 1; 34: 1450-1455
        • Yoo S.-H.
        • Kim J.S.
        • Kwon S.U.
        • Yun S.-C.
        • Koh J.-Y.
        • Kang D.-W.
        Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients.
        Arch Neurol. 2008 Jan 1; 65: 39-43
        • Masrur S.
        • Smith E.E.
        • Saver J.L.
        • Reeves M.J.
        • Bhatt D.L.
        • Zhao X.
        • et al.
        Dysphagia screening and hospital-acquired pneumonia in patients with acute ischemic stroke: findings from Get with the Guidelines–Stroke.
        J Stroke Cerebrovasc Dis. 2013 Nov; 22: e301-e309
        • Finlayson O.
        • Kapral M.
        • Hall R.
        • Asllani E.
        • Selchen D.
        • Saposnik G.
        • et al.
        Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke.
        Neurology. 2011 Oct 4; 77: 1338-1345
        • Ickenstein G.W.
        • Riecker A.
        • Höhlig C.
        • Müller R.
        • Becker U.
        • Reichmann H.
        • et al.
        Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept.
        J Neurol. 2010 Sep 10; 257: 1492-1499
        • Yeh S.-J.
        • Huang K.-Y.
        • Wang T.-G.
        • Chen Y.-C.
        • Chen C.-H.
        • Tang S.-C.
        • et al.
        Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit.
        J Neurol Sci. 2011 Jul 15; 306: 38-41
        • Sørensen R.T.
        • Rasmussen R.S.
        • Overgaard K.
        • Lerche A.
        • Johansen A.M.
        • Lindhardt T.
        Dysphagia screening and intensified oral hygiene reduce pneumonia after stroke.
        J Neurosci Nurs. 2013 Jun; 45: 139-146
        • Bax L.
        • McFarlane M.
        • Green E.
        • Miles A.
        Speech-language pathologist-led fiberoptic endoscopic evaluation of swallowing: functional outcomes for patients after stroke.
        J Stroke Cerebrovasc Dis. 2014 Mar; 23: e195-200
        • Kim J.H.
        • Byun H.Y.
        • Son S.
        • Lee J.H.
        • Yoon C.H.
        • Lee E.S.
        • et al.
        Retrospective assessment of the implementation of critical pathway in stroke patients in a single university hospital.
        Ann Rehabil Med. 2014 Oct; 38: 603-611
        • Titsworth W.L.
        • Abram J.
        • Fullerton A.
        • Hester J.
        • Guin P.
        • Waters M.F.
        • et al.
        Prospective quality initiative to maximize dysphagia screening reduces hospital-acquired pneumonia prevalence in patients with stroke.
        Stroke. 2013 Nov 1; 44: 3154-3160
        • Cocho D.
        • Sagales M.
        • Cobo M.
        • Homs I.
        • Serra J.
        • Pou M.
        • et al.
        Lowering bronchoaspiration rate in an acute stroke unit by means of a 2 volume/3 texture dysphagia screening test with pulsioximetry.
        Neurologia. 2017 Jan–Feb; 32 (https://doi.org/10.1016/j.nrl.2014.12.005. Epub 2015 Feb 7): 22-28
        • Al-Khaled M.
        • Matthis C.
        • Binder A.
        • Mudter J.
        • Schattschneider J.
        • Pulkowski U.
        • et al.
        Dysphagia in patients with acute ischemic stroke: early dysphagia screening may reduce stroke-related pneumonia and improve stroke outcomes.
        Cerebrovasc Dis. 2016 Apr 13; 42: 81-89
        • Lakshminarayan K.
        • Tsai A.W.
        • Tong X.
        • Vazquez G.
        • Peacock J.M.
        • George M.G.
        • et al.
        Utility of dysphagia screening results in predicting poststroke pneumonia.
        Stroke. 2010 Dec 1; 41: 2849-2854
        • Evans A.
        • Perez I.
        • Harraf F.
        • Melbourn A.
        • Steadman J.
        • Donaldson N.
        • et al.
        Can differences in management processes explain different outcomes between stroke unit and stroke-team care?.
        Lancet (London, England). 2001 Nov 10; 358: 1586-1592
        • Hinchey J.A.
        • Shephard T.
        • Furie K.
        • Smith D.
        • Wang D.
        • Tonn S.
        • et al.
        Formal dysphagia screening protocols prevent pneumonia.
        Stroke. 2005 Sep 1; 36: 1972-1976
        • Bray B.D.
        • Smith C.J.
        • Cloud G.C.
        • Enderby P.
        • James M.
        • Paley L.
        • et al.
        The association between delays in screening for and assessing dysphagia after acute stroke, and the risk of stroke-associated pneumonia.
        J Neurol Neurosurg Psy. 2017 Jan; 88: 25-30
        • DePppo K.L.
        • Holas M.A.
        • Reding M.J.
        Validation of the 3-oz water swallow test for aspiration following stroke.
        Arch Neurol. 1992 Dec; 49: 1259-1261
        • Maeshima S.
        • Osawa A.
        • Hayashi T.
        • Tanahashi N.
        Elderly age, bilateral lesions, and severe neurological deficit are correlated with stroke-associated pneumonia.
        J Stroke Cerebrovasc Dis. 2014 Mar; 23: 484-489
        • Brodsky M.B.
        • Suiter D.M.
        • González-Fernández M.
        • Michtalik H.J.
        • Frymark T.B.
        • Venediktov R.
        • et al.
        Screening accuracy for aspiration using bedside water swallow tests: a systematic review and meta-analysis.
        Chest. 2016 Jul; 150: 148-163
        • Trapl M.
        • Enderle P.
        • Nowotny M.
        • Teuschl Y.
        • Matz K.
        • Dachenhausen A.
        • et al.
        Dysphagia bedside screening for acute-stroke patients: the Gugging Swallowing Screen.
        Stroke. 2007 Nov 1; 38: